Heritage Family Offices LLP lessened its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 24.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,660 shares of the technology company's stock after selling 5,972 shares during the quarter. Heritage Family Offices LLP's holdings in Relx were worth $941,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also recently made changes to their positions in the stock. CENTRAL TRUST Co grew its holdings in Relx by 1,290.2% during the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock valued at $26,000 after buying an additional 529 shares in the last quarter. Transce3nd LLC purchased a new stake in shares of Relx during the fourth quarter valued at $40,000. Sierra Ocean LLC bought a new position in Relx in the 4th quarter worth about $43,000. Brown Brothers Harriman & Co. grew its stake in Relx by 218.5% in the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock worth $44,000 after purchasing an additional 662 shares in the last quarter. Finally, Private Trust Co. NA grew its position in shares of Relx by 19.2% during the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock worth $56,000 after buying an additional 199 shares in the last quarter. 15.02% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several equities research analysts have weighed in on the stock. The Goldman Sachs Group began coverage on shares of Relx in a research note on Wednesday, March 26th. They issued a "buy" rating for the company. Wall Street Zen lowered shares of Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. Finally, Morgan Stanley reissued an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Relx currently has a consensus rating of "Buy".
View Our Latest Report on Relx
Relx Price Performance
NYSE RELX traded up $0.31 on Wednesday, hitting $54.37. The company had a trading volume of 1,378,368 shares, compared to its average volume of 725,061. The company has a market capitalization of $100.36 billion, a PE ratio of 29.23, a PEG ratio of 2.73 and a beta of 0.86. The company's fifty day moving average price is $52.45 and its 200-day moving average price is $49.57. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. Relx Plc has a 12-month low of $43.45 and a 12-month high of $56.33.
About Relx
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Articles

Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.